Related Experiment Video

Updated: Jun 2, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

The role of statins in stroke

Ugo Paliani1, Stefano Ricci

  • 1Division of Internal Medicine, ASL 1 Umbria, via Engels-Voc.Chioccolo, 06012 Città di Castello (Perugia), Italy. ugo.paliani@ASLasl1.umbria.it

Internal and Emergency Medicine
|May 6, 2011
PubMed

Insights

Statin therapy significantly reduces stroke risk in both primary and secondary prevention, even with elevated cholesterol or hs-CRP. Clinical trials confirm statins

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Pharmacology

Background:

  • Epidemiological studies suggest a link between cholesterol levels and stroke risk, though evidence is not definitive.
  • Clinical trials for coronary benefits of statins provide compelling evidence for their role in reducing stroke risk.
  • Stroke pathophysiology differs from heart attack, necessitating specific trials to confirm statin efficacy and risks in stroke patients.

Purpose of the Study:

  • To evaluate the efficacy of statin therapy in stroke prevention.
  • To assess the benefits and risks of statins in primary and secondary stroke prevention populations.

Main Methods:

  • Analysis of clinical therapy trials, including those primarily designed for coronary benefits.
  • Review of specific trials conducted in stroke patient populations.
  • Examination of statin effectiveness in primary prevention based on low-density lipoprotein (LDL) and hs-CRP levels.

Main Results:

  • Statin therapy demonstrates a reduction in stroke risk.
  • In primary prevention, statins are effective for individuals with elevated LDL or hs-CRP.
  • In secondary prevention, statins achieve an absolute reduction in recurrent stroke, with a number needed to treat of 45 over 5 years.

Conclusions:

  • Statin therapy is beneficial for reducing stroke risk across different patient populations.
  • Statins offer advantages in both primary and secondary stroke prevention.
  • The findings support the use of statins for stroke risk reduction, supported by robust clinical trial data.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...